$EXPE

Morgan Stanley Cuts Expedia (EXPE) to Underweight as Rivals Pull Ahead on Users

Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 price target, citing flat user growth compared to rivals like Booking.com and Airbnb. The analyst noted Expedia's higher marketing costs and exposure to AI-driven search tools. Despite this, Expedia's B2B segment grew 21% in Q2, and the company raised its full-year revenue and margin outlook. The stock has fallen since the downgrade.

Original reporting
Published Sep 22, 2026, 12:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 1:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley Cuts Expedia (EXPE) to Underweight as Rivals Pull Ahead on Users — source image
Decision brief

The 30-second read

$EXPEBearishMed
01

Why it matters

The downgrade introduces a bearish bias, but Expedia's strong B2B segment and raised outlook provide a nuanced view.

02

Market read

Analyst downgrade of a large-cap travel company may trigger short-term price pressure while underlying fundamentals show mixed signals.

03

What to watch

Buyback program and double-digit B2B bookings growth may sustain earnings despite user metrics.

Relevance 7/10Novelty 6/10Timing: recent downgrade

Background

Morgan Stanley analyst Matthew Cost highlighted flat MAU versus competitor growth, prompting the rating cut.

Company-level read

Ticker impact

$EXPEBearishMedium confidence
Context

Morgan Stanley cut Expedia to Underweight and set a $235 price target, 20% below current price.

Expected impact

Potential short-term decline of 3-5% as investors adjust expectations.

Evidence & confidence

Downgrade is a fresh analyst action; market often reacts to such rating changes, especially for a large-cap travel platform.

Market effects

Travel and online booking sector may see broader scrutiny as rivals like Booking.com and Airbnb post stronger user growth.

U.S. travel stocks could face pressure in the near term.

Limited to investors tracking travel platforms and related ETFs.

Counterpoint

Expedia's B2B growth and raised guidance could offset user stagnation, supporting a hold or buy.

Key entities

  • Morgan Stanley

    Equity research firm issuing the downgrade.

  • Expedia Group, Inc.

    Online travel booking platform.

Related articles

$EXPEMed

Feel like you’re overpaying for hotels? Blame Expedia, a new lawsuit says.

A lawsuit accuses Expedia Group of violating antitrust laws by enforcing contracts that prevent hotels from offering lower rates elsewhere, allegedly inflating prices by 15% to 30%. Expedia denies the claims, stating it provides competitive offerings. The suit seeks class-action status and covers Expedia's brands, including Expedia.com and Hotels.com. Expedia faces increased competition from direct hotel bookings, according to an SEC filing.

$EXPEMed

Expedia accused of inflating hotel prices in new lawsuit

A class-action lawsuit filed against Expedia alleges the company artificially inflates hotel rates by prohibiting lower prices elsewhere, including hotels' own websites. The lawsuit claims Expedia charges 15-30% commissions and punishes hotels that offer lower prices. Expedia denies the allegations, stating it provides competitive offerings. The plaintiffs argue Expedia's monopoly power increases trip costs.

$ABNBMed

Airbnb Slides to $150 as Wall Street Fears AI Will Skip the Middleman

Airbnb (ABNB) fell 8% to $150 despite 17% revenue growth, as investors reacted to Meta's AI agent Muse, which could bypass travel intermediaries. Booking Holdings (BKNG) and Expedia (EXPE) also dropped. Airbnb's unique inventory and direct host-guest relationships may mitigate AI impact. The stock's consensus target is $184.35.

$METAMed

Meta’s Muse Drags Down Stocks That Depend on ‘Consumer Inertia’

Shares of banks, insurers, and travel agencies fell as investors worry about Meta's AI agent, Muse, disrupting industries reliant on consumer inertia. Meta's stock rose 11% on Monday. Affected companies include JPMorgan, Morgan Stanley, Allstate, Charles Schwab, Expedia, and Booking Holdings. Goldman Sachs identifies telecoms, insurance, and utilities as sectors at risk.